Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.

Longitudinal predictions suggested that patients with baseline NIH-AI scores of ≥8 were most sensitive to improvement over 6-12 months. Viable approaches such as this may enable the use of urine samples to monitor LN over time.